Tarlatamab Improves Overall Survival in Small Cell Lung Cancer

Imdelltra ® demonstrated superior overall survival in small cell lung cancer. News release. Amgen. April 11, 2025. Read More

Roche’s Tecentriq With Lurbinectedin Increases Survival From Small-Cell Lung Cancer, Study Says - WSJ - The Wall Street Journal

Roche’s Tecentriq With Lurbinectedin Increases Survival From Small-Cell Lung Cancer, Study Says Late-stage trials showed the combination led to a 27% reduction in the risk of death, the company said ... Read More

What Is Small Cell Lung Cancer (SCLC)?

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC. Read More

Imdelltra May Improve Survival in Small Cell Lung Cancer

Imdelltra received accelerated approval from the U.S. Food and Drug Administration in May 2024 for patients with extensive-stage small cell lung cancer with disease progression on or after ... Read More

Nivolumab Plus Chemotherapy Improves Survival in Lung Cancer - Medscape

TOPLINE: Adding nivolumab to neoadjuvant chemotherapy significantly improved 5-year overall survival among patients with resectable non-small cell lung cancer (NSCLC), according to findings from a ... Read More

Tarlatamab Deemed “Preferable” Second-Line Therapy for Small Cell Lung Cancer

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial. Read More

Amgen’s Imdelltra Demonstrates Significant Overall Survival Improvement in Small Cell Lung Cancer

In the Phase III DeLLphi-304 trial, patients with small cell lung cancer administered Imdelltra achieved a statistically significant and clinically meaningful improvement in overall survival compared ... Read More

Lurbinectedin Plus Atezolizumab Under Review for Extensive-Stage Small-Cell Lung Cancer

Lurbinectedin plus atezolizumab significantly reduced the risk of disease progression or death by 46% compared with atezolizumab alone. Read More

Why is lung cancer increasing among non-smokers? | Fox News

Researchers at the International Agency for Research on Cancer (IARC) analyzed global trends in four main lung cancer subtypes: adenocarcinoma, squamous cell carcinoma, small-cell carcinoma and ... Read More

Genentech’s Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer - Yahoo Finance

Genentech’s Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung Cancer Business Wire Mon, Jun 2, 2025, 4:05 PM 9 min read ... Read More

Ivonescimab Plus Chemotherapy Demonstrates Statistically Significant and Clinically Meaningful Improvement in Progression-Free Survival in Patients with EGFR-Mutant Non-Small ...

Summit has begun its clinical development of ivonescimab in non-small cell lung cancer (NSCLC), commencing enrollment in 2023 in two multiregional Phase III clinical trials, HARMONi and HARMONi-3 ... Read More

Roche's Tecentriq With Lurbinectedin Increases Survival to Small-Cell Lung Cancer, Study Says - Morningstar

Global News Select; ... Roche's Tecentriq With Lurbinectedin Increases Survival to Small-Cell Lung Cancer, Study Says Provided by Dow Jones Jun 3, 2025, 5:48:00 AM. By Adam Whittaker . Read More